128 related articles for article (PubMed ID: 1345741)
1. Blood-brain barrier changes in multiple sclerosis.
Trojano M; Manzari C; Livrea P
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):55-64. PubMed ID: 1345741
[TBL] [Abstract][Full Text] [Related]
2. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
3. Does damage of perivascular astrocytes in multiple sclerosis plaques participate in blood-brain barrier permeability?
Rafałowska J; Krajewski S; Dolińska E; Dziewulska D
Neuropatol Pol; 1992; 30(1):73-80. PubMed ID: 1484610
[TBL] [Abstract][Full Text] [Related]
4. The blood-brain barrier in cortical multiple sclerosis lesions.
van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
[TBL] [Abstract][Full Text] [Related]
5. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.
McQuaid S; Cunnea P; McMahon J; Fitzgerald U
Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657
[TBL] [Abstract][Full Text] [Related]
6. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
7. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
8. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle C; Alvarez JI; Prat A
FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
[TBL] [Abstract][Full Text] [Related]
9. [Blood-brain barrier in multiple sclerosis: mechanisms of its breakdown and repair].
Kanda T
Nihon Rinsho; 2003 Aug; 61(8):1402-8. PubMed ID: 12962030
[TBL] [Abstract][Full Text] [Related]
10. The blood-brain barrier (BBB) permeability in multiple sclerosis.
Rafałowska J; Krajewski S; Dolińska E
Neuropatol Pol; 1990; 28(1-2):41-54. PubMed ID: 2097537
[No Abstract] [Full Text] [Related]
11. [Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin].
Kohriyama T; Maruyama H; Kurokawa K; Harada T; Nakamura S
Rinsho Shinkeigaku; 1997 Apr; 37(4):287-91. PubMed ID: 9248336
[TBL] [Abstract][Full Text] [Related]
12. The pathology of multiple sclerosis.
Sobel RA
Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
[TBL] [Abstract][Full Text] [Related]
13. On the role of interleukin-2 (IL-2) in multiple sclerosis (MS). IL-2-mediated endothelial cell activation.
Gallo P; Pagni S; Piccinno MG; Giometto B; Argentiero V; Chiusole M; Bozza F; Tavolato B
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):65-8. PubMed ID: 1345742
[TBL] [Abstract][Full Text] [Related]
14. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
Stolp HB; Dziegielewska KM
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
[TBL] [Abstract][Full Text] [Related]
15. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
16. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
17. Infiltration of inflammatory cells through brain endothelium.
Couraud PO
Pathol Biol (Paris); 1998 Mar; 46(3):176-80. PubMed ID: 9769913
[TBL] [Abstract][Full Text] [Related]
18. Development of the blood-brain barrier.
Engelhardt B
Cell Tissue Res; 2003 Oct; 314(1):119-29. PubMed ID: 12955493
[TBL] [Abstract][Full Text] [Related]
19. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenesis of multiple sclerosis.
Agrawal SM; Yong VW
Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
